Delivery Order SPE2DB22D3501-SPE2DB25FWP90
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for sulfamethoxazole-trimethoprim DS tablets (100-count bottles) valued at $4,627.09. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is executed as a child order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sulfamethoxazole-Trimethoprim Double Strength tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,452.95 and has a firm fixed price structure with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets in quantities of 100 units. The contract carries a ceiling value of $6,714.50 and employs a firm fixed price structure with an ultimate completion date of August 11, 2025. This is a non-set-aside delivery order, awarded competitively, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,528.58 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim (SMP) DS tablets in quantities of 500 units. The contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitively awarded, non-set-aside procurement with firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,017.01 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500 count) on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is structured as a child order...
- The Defense Logistics Agency awarded a $1,287.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-Trimethoprim (an antibiotic combination medication) in tablet form, with 90-count packaging. The contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside transaction executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sulfamethoxazole-TMP DS tablets (500-count) with a ceiling value of $7,704.74. This firm fixed-price delivery order, which is expected to be completed by August 8, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,307.48 to AmerisourceBergen Drug Corp for the supply of Sulfamethoxazole-Trimethoprim DS tablets (500-count packages). This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sulfamethoxazole-TMP DS tablets (100-count packages) on July 23, 2025, with a ceiling value of $1,214.54 and an ultimate completion date of July 24, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Medical Supply Chain, a component of the Defense Logistics Agency, on July 28, 2025, for the supply of Sulfamethoxazole-TMP DS Tablet in quantities of 100 units. This is a firm fixed price delivery order valued at $1,513.67, with an ultimate completion date of July 29, 2025. The contract is not set-aside and was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWP90Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sulfamethoxazole-Trimethoprim DS tablets (100-count units) with a ceiling value of $5,185.10. This firm fixed-price delivery order, which is scheduled for completion by July 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The Sulfamethoxazole-Trimethoprim antibiotic procurement supports the Defense Logistics Agency's medical supply chain objectives, delivering essential pharmaceutical commodities to military healthcare programs and related federal healthcare systems. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive capability in fulfilling competitive medical supply requirements across therapeutic domains, ranging from specialty medications to generic drugs and vaccines. The company's role as a critical vendor for DLA's pharmaceutical procurement operations underscores its position within the federal medical logistics infrastructure that supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 7/28/25 |